FDA to review whether to allow more access to certain peptides
The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized medications made by compounding pharmacies.
20 hours ago
0
2
Health Care Quality, Access, and Evaluation: News and Research on Clinical Studies as Topic
MeSH tree: N05.715.360.330.250
New anti-clotting medication lowers risk of stroke without added bleeding
A large international study has found that asundexian, an investigational anti-clotting medication, reduces the risk of a stroke in people who recently experienced a stroke or transient ischemic attack (TIA) caused by a clot ...
Apr 15, 2026
0
71
New drug doubles 1-year survival in pancreatic cancer trial
Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a year after diagnosis. But a new drug developed at Northwestern University may soon help patients live ...
Apr 14, 2026
0
23
'More therapy, earlier' didn't boost recovery in NZ stroke rehabilitation trial
A clinical trial led by University of Auckland researchers found that high-intensity therapy for patients begun within two weeks of a stroke did not improve hand and arm recovery beyond standard care. Targeting new treatments ...
Mar 26, 2026
0
2
Lyme disease vaccine shows over 70% efficacy, but phase three misses main goal
An experimental vaccine for Lyme disease is broadly effective, pharmaceutical companies Pfizer and Valneva announced Monday; however, the latter firm's shares fell because the clinical trial did not reach its main goal.
Mar 23, 2026
0
6
Early clinical results deliver encouraging milestone for malaria drug candidate
Findings from two early clinical studies suggest a new dual-action antimalarial drug candidate is well tolerated in humans. The first-in-class clinical candidate, MK7602, is being developed by WEHI and global biopharmaceutical ...
Mar 19, 2026
0
19
FDA provides fast track designation to nipocalimab for systemic lupus erythematosus
Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE).
Mar 12, 2026
0
6
Targeting the untargetable cancer—rezatapopt, an oral p53 reactivator
Memorial Sloan Kettering Cancer Center investigators and collaborators have tested rezatapopt, an oral p53 reactivator designed for tumors with TP53 Y220C, and observed antitumor activity across multiple solid tumor types ...
Vaccine shows protection against severe childhood diarrhea
Each year, tens of thousands of children under 5 die from diarrheal disease caused by enterotoxigenic Escherichia coli (ETEC), primarily in low-income countries. A new ETEC vaccine has shown promising results in reducing ...
Feb 18, 2026
0
6
Single dose of a psychedelic drug can rapidly reduce depressive symptoms, clinical trial suggests
A single dose of the psychedelic drug dimethyltryptamine (DMT), given with psychological support, rapidly reduced depressive symptoms in 34 adults with major depressive disorder, according to a clinical trial published in ...
Feb 17, 2026
0
97
